Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET-letter

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)4290
Number of pages1
JournalClinical Cancer Research
Volume19
Issue number15
DOIs
Publication statusPublished - Aug 1 2013

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this